MiR-376a-3p increases cell apoptosis in acute myeloid leukemia by targeting MT1X

References

• Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med. 1999;341(14):1051–1062. doi:10.1056/NEJM199909303411407. PMID: 10502596.
   PubMed Web of Science ®Google Scholar
• Ferrara F, Schiffer CA. Acute myeloid leukaemia in adults. Lancet. 2013;381(9865):484–495. doi:10.1016/S0140-6736(12)61727-9. PMID: 23399072.
   PubMed Web of Science ®Google Scholar
• Coyle P, Philcox JC, Carey LC, Rofe AM. Metallothionein: the multipurpose protein. Cell Mol Life Sci. 2002;59(4):627–647. doi:10.1007/s00018-002-8454-2. PMID: 12022471.
   PubMed Web of Science ®Google Scholar
• Pedersen MO, Larsen A, Stoltenberg M, Penkowa M. The role of metallothionein in oncogenesis and cancer prognosis. Prog Histochem Cytochem. 2009;44(1):29–64. doi:10.1016/j.proghi.2008.10.001. PMID: 19348910.
   PubMedGoogle Scholar
• Duerr GD, Dewald D, Schmitz EJ, Verfuerth L, Keppel K, Peigney C, Ghanem A, Welz A, Dewald O. Metallothioneins 1 and 2 Modulate Inflammation and Support Remodeling in Ischemic Cardiomyopathy in Mice. Mediators Inflamm. 2016;2016:7174127. doi:10.1155/2016/7174127. PMID: 27403038.
   PubMed Web of Science ®Google Scholar
• Ugajin T, Nishida K, Yamasaki S, Suzuki J, Mita M, Kubo M, Yokozeki H, Hirano T. Zinc-binding metallothioneins are key modulators of IL-4 production by basophils. Mol Immunol. 2015;66(2):180–188. doi:10.1016/j.molimm.2015.03.002. PMID: 25801306.
   PubMed Web of Science ®Google Scholar
• Tiwari R, Pandey SK, Goel S, Bhatia V, Shukla S, Jing X, Dhanasekaran SM, Ateeq B. SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression. Oncogenesis. 2015;4:e162. doi:10.1038/oncsis.2015.23. PMID: 26258891.
   PubMed Web of Science ®Google Scholar
• Yan DW, Fan JW, Yu ZH, Li MX, Wen YG, Li DW, Zhou CZ, Wang XL, Wang Q, Tang HM, et al. Downregulation of metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue. Biochim Biophys Acta. 2012;1822(6):918–926. 10.1016/j.bbadis.2012.02.021. PMID: 22426038.
   PubMed Web of Science ®Google Scholar
• Yap X, Tan HY, Huang J, Lai Y, Yip GW, Tan PH, Bay BH. Over-expression of metallothionein predicts chemoresistance in breast cancer. J Pathol. 2009;217(4):563–570. doi:10.1002/path.2489. PMID: 19116991.
   PubMed Web of Science ®Google Scholar
• Arriaga JM, Greco A, Mordoh J, Bianchini M. Metallothionein 1G and zinc sensitize human colorectal cancer cells to chemotherapy. Mol Cancer Ther. 2014;13(5):1369–1381. doi:10.1158/1535-7163.MCT-13-0944. PMID: 24634414.
   PubMed Web of Science ®Google Scholar
• Liu Z, Ye Q, Wu L, Gao F, Xie H, Zhou L, Zheng S, Xu X. Metallothionein 1 family profiling identifies MT1X as a tumor suppressor involved in the progression and metastatic capacity of hepatocellular carcinoma. Mol Carcinog. 2018;57(11):1435–1444. doi:10.1002/mc.22846. PMID: 29873415.
   PubMed Web of Science ®Google Scholar
• Peng B, Gu Y, Xiong Y, Zheng G, He Z. Microarray-assisted pathway analysis identifies MT1X & NFkappaB as mediators of TCRP1-associated resistance to cisplatin in oral squamous cell carcinoma. PLoS One. 2012;7(12):e51413. doi:10.1371/journal.pone.0051413. PMID: 23251525.
   PubMed Web of Science ®Google Scholar
• Duval D, Trouillas M, Thibault C, Dembele D, Diemunsch F, Reinhardt B, Mertz AL, Dierich A, Boeuf H. Apoptosis and differentiation commitment: novel insights revealed by gene profiling studies in mouse embryonic stem cells. Cell Death Differ. 2006;13(4):564–575. doi:10.1038/sj.cdd.4401789. PMID: 16311515.
   PubMed Web of Science ®Google Scholar
• Maghdooni Bagheri P, Rahman MT, Van Soest S, De Ley M. Differential quantitative zinc-induced expression of human metallothionein isogenes in haematopoietic precursor cell lines. J Trace Elem Med Biol. 2009;23(2):124–131. doi:10.1016/j.jtemb.2009.02.003. PMID: 19398060.
   PubMed Web of Science ®Google Scholar
• Maghdooni Bagheri P, Govaerts I, De Ley M. Role of metallothionein in differentiation of leukemia cells. Mol Biol Rep. 2011;38(5):3017–3022. doi:10.1007/s11033-010-9967-7. PMID: 20127519.
   PubMed Web of Science ®Google Scholar
• Sauerbrey A, Zintl F, Hermann J, Volm M. Multiple resistance mechanisms in acute nonlymphoblastic leukemia (ANLL). Anticancer Res. 1998;18(2B):1231–1236. PMID: 9615793.
   PubMed Web of Science ®Google Scholar
• Imoto A, Okada M, Okazaki T, Kitasato H, Harigae H, Takahashi S. Metallothionein-1 isoforms and vimentin are direct PU.1 downstream target genes in leukemia cells. J Biol Chem. 2010;285(14):10300–10309. doi:10.1074/jbc.M109.095810. PMID: 20139074.
   PubMed Web of Science ®Google Scholar
• Si M, Lang J. The roles of metallothioneins in carcinogenesis. J Hematol Oncol. 2018;11(1):107. doi:10.1186/s13045-018-0645-x. PMID: 30139373.
   PubMed Web of Science ®Google Scholar
• Abdel-Mageed AB, Agrawal KC. Activation of nuclear factor kappaB: potential role in metallothionein-mediated mitogenic response. Cancer Res. 1998;58(11):2335–2338. PMID: 9622069.
   PubMed Web of Science ®Google Scholar
• Ganger R, Garla R, Mohanty BP, Bansal MP, Garg ML. Protective Effects of Zinc Against Acute Arsenic Toxicity by Regulating Antioxidant Defense System and Cumulative Metallothionein Expression. Biol Trace Elem Res. 2016;169(2):218–229. doi:10.1007/s12011-015-0400-x. PMID: 26113309.
   PubMed Web of Science ®Google Scholar
• Krizkova S, Kepinska M, Emri G, Rodrigo MA, Tmejova K, Nerudova D, Kizek R, Adam V. Microarray analysis of metallothioneins in human diseases–A review. J Pharm Biomed Anal. 2016;117:464–473. doi:10.1016/j.jpba.2015.09.031. PMID: 26454339.
   PubMed Web of Science ®Google Scholar
• Leierer J, Rudnicki M, Braniff SJ, Perco P, Koppelstaetter C, Muhlberger I, Eder S, Kerschbaum J, Schwarzer C, Schroll A, et al. Metallothioneins and renal ageing. Nephrol Dial Transplant. 2016;31(9):1444–1452. 10.1093/ndt/gfv451. PMID: 26908771.
   PubMed Web of Science ®Google Scholar
• DiDonato JA, Mercurio F, Karin M. NF-kappaB and the link between inflammation and cancer. Immunol Rev. 2012;246(1):379–400. doi:10.1111/j.1600-065X.2012.01099.x. PMID: 22435567.
   PubMed Web of Science ®Google Scholar
• Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5(10):749–759. doi:10.1038/nri1703. PMID: 16175180.
   PubMed Web of Science ®Google Scholar
• Lee CH, Jeon YT, Kim SH, Song YS. NF-kappaB as a potential molecular target for cancer therapy. Biofactors. 2007;29(1):19–35. doi:10.1002/biof.5520290103. PMID: 17611291.
   PubMed Web of Science ®Google Scholar
• Bayoumi AS, Sayed A, Broskova Z, Teoh JP, Wilson J, Su H, Tang YL, Kim IM. Crosstalk between Long Noncoding RNAs and MicroRNAs in Health and Disease. Int J Mol Sci. 2016;17(3):356. doi:10.3390/ijms17030356. PMID: 26978351.
   PubMed Web of Science ®Google Scholar
• Raitoharju E, Seppala I, Oksala N, Lyytikainen LP, Raitakari O, Viikari J, Ala-Korpela M, Soininen P, Kangas AJ, Waldenberger M, et al. Blood microRNA profile associates with the levels of serum lipids and metabolites associated with glucose metabolism and insulin resistance and pinpoints pathways underlying metabolic syndrome: the cardiovascular risk in Young Finns Study. Mol Cell Endocrinol. 2014;391(1–2):41–49. 10.1016/j.mce.2014.04.013. PMID: 24784704.
   PubMed Web of Science ®Google Scholar
• Plaisance-Bonstaff K, Renne R. Viral miRNAs. Methods Mol Biol. 2011;721:43–66. doi:10.1007/978-1-61779-037-9_3. PMID: 21431678.
   PubMedGoogle Scholar
• Li Y, Wu Y, Sun Z, Wang R, Ma D. MicroRNA376a inhibits cell proliferation and invasion in glioblastoma multiforme by directly targeting specificity protein 1. Mol Med Rep. 2018;17(1):1583–1590. doi:10.3892/mmr.2017.8089. PMID: 29257212.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Yin L, Chen H, Yang S, Pan C, Lu S, Miao M, Jiao B. miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma. FEBS Lett. 2012;586(16):2396–2403. doi:10.1016/j.febslet.2012.05.054. PMID: 22684007.
   PubMed Web of Science ®Google Scholar
• Formosa A, Markert EK, Lena AM, Italiano D, Finazzi-Agro E, Levine AJ, Bernardini S, Garabadgiu AV, Melino G, Candi E. MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. Oncogene. 2014;33(44):5173–5182. doi:10.1038/onc.2013.451. PMID: 24166498.
   PubMed Web of Science ®Google Scholar
• Wang Y, Cong W, Wu G, Ju X, Li Z, Duan X, Wang X, Gao H. MiR-376a suppresses the proliferation and invasion of non-small-cell lung cancer by targeting c-Myc. Cell Biol Int. 2018;42(1):25–33. doi:10.1002/cbin.10828. PMID: 28741879.
   PubMed Web of Science ®Google Scholar
• Wang Y, Jiang F, Xiong Y, Cheng X, Qiu Z, Song R. LncRNA TTN-AS1 sponges miR-376a-3p to promote colorectal cancer progression via upregulating KLF15. Life Sci. 2020;244:116936. doi:10.1016/j.lfs.2019.116936. PMID: 31610194.
   PubMed Web of Science ®Google Scholar
• Chen L, Jing SY, Liu N, Han S, Yang YK, Han MY, Yan CX. MiR-376a-3p alleviates the development of glioma through negatively regulating KLF15. Eur Rev Med Pharmacol Sci. 2020;24(22):11666–11674. doi:10.26355/eurrev_202011_23811. PMID: 33275234.
   PubMed Web of Science ®Google Scholar
• Zhou G, Jiang H, Ma L. MicroRNA376a inhibits cell proliferation and invasion in osteosarcoma via directly targeting SATB1. Mol Med Rep. 2018;18(3):3521–3528. doi:10.3892/mmr.2018.9344. PMID: 30085330.
   PubMed Web of Science ®Google Scholar